Evidence map›Paper›PMID 33798761›Full record

ArticleAnaesthesia, critical care & pain medicine2021

Anticoagulation in COVID-19: not strong for too long?

Charles Tacquard, Alexandre Mansour, Alexandre Godon, Yves Gruel, Sophie Susen, Anne Godier, Pierre Albaladejo

Abstract readEditorial
In one paragraph

Article in Anaesthesia, critical care & pain medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Anticoagulation in COVID-19.Lancet (London, England) · 2022
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Charles TacquardDepartment of Anaesthesia and Intensive Care, Hôpitaux Universitaires de Strasbourg, 1, Place de l'Hôpital, 67091 Strasbourg Cedex, France. Electronic address: charlesambroise.tacquard@chru-strasbourg.fr.
Alexandre MansourDepartment of Anaesthesiology Critical Care Medicine and Perioperative Medicine, CHU de Rennes, Rennes, France.
Alexandre GodonDepartment of Anaesthesiology and Critical Care, Grenoble Alpes University Hospital, Grenoble, France.
Yves GruelDepartment of Haematology-Haemostasis, Tours University Hospital, France.
Sophie SusenHeart and Lung Institute, Haemostasis Department, CHU Lille, 59037 Lille Cedex, France.
Anne GodierDepartment of Anaesthesiology and Critical Care, European Georges Pompidou Hospital, Assistance Publique-Hôpitaux de Paris, Paris University, Paris, France.
Pierre AlbaladejoDepartment of Anaesthesiology and Critical Care, Grenoble Alpes University Hospital, Grenoble, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnticoagulantsCOVID-19Critical IllnessExtracorporeal Membrane OxygenationHemorrhageHumansMultiple Organ FailureRandomized Controlled Trials as TopicThrombosisTime FactorsAnticoagulantsAnticoagulationBleedingComplicationsCOVID-19Thrombosis

Identifiers

PMID33798761
PMCPMC8008784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.